Several Positive Developments Lifted Roivant (ROIV) in Q3
Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here.
Roivant Sciences Ltd. (ROIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | QVT Financial Daniel Gold | 65,793,779 | $759,260,210 | -2% | 65.33% |
| 2. | Viking Global Andreas Halvorsen | 54,099,066 | $624,303,222 | -22% | 2.27% |
| 3. | Rubric Capital Management David Rosen | 22,400,000 | $258,496,000 | -3% | 4.21% |
| 4. | Two Seas Capital Sina Toussi | 9,724,893 | $112,225,265 | -6% | 18.18% |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 8,686,476 | $100,241,933 | +9% | 0.84% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 4,000,000 | Large Shareholder | 102,849,443 | 2022-11-10 | Filing | |
| $3.91 | 8,600 | Large Shareholder | 98,849,443 | 2022-04-25 | Filing | |
| $3.83 | 31,685 | Large Shareholder | 98,840,843 | 2022-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.32 | 100,000 | 606,525 | 2024-11-20 | Filing | ||
| $11.65 | 100,000 | 617,470 | 2024-10-21 | Filing | ||
| $11.82 | 876,000 | 22,179,358 | 2024-09-26 | Filing | ||
| $11.77 | 50,000 | 23,055,358 | 2024-09-25 | Filing | ||
| $11.77 | 134,948 | 1,277,178 | 2024-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 73,031,667 | $820,145,620 | 7.29% | |
| 2. | 36,976,248 | $415,243,265 | 0.03% | |
| 3. | 21,927,044 | $246,240,711 | 0.02% | |
| 4. | 20,805,601 | $233,646,898 | 0% | |
| 5. | 13,727,418 | $154,158,904 | 0% |
News See All
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Roivant Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
8 High Growth UK Stocks to Invest In
According to a KPMG report, the United Kingdom’s GDP growth is projected to slow in the second half of 2024 but is expected to rise slightly to 1.2% in 2025.
10 Most Promising Mid-Cap Stocks According to Hedge Funds
September closed on a high note, opening a wealth of opportunities for investors.
10 Best NASDAQ Stocks Under $20 to Buy
The close of September has seen the much awaited interest rate cut from the Federal Reserve materialize.
10 Best Stocks Under $15 To Buy Now
While September is usually the toughest month for the stock market, it is delivering solid results this time.
7 Best Small Company Stocks To Invest In
The Fed's decision to cut interest rates by 50 basis points in September significantly impacted the market.
10 Best NASDAQ Stocks Under $50 to Buy
The close of 2024's third quarter is seeing Wall Street rejoice as the Federal Reserve finally delivers its highly awaited interest rate cut.
10 Best Guru Stocks To Buy Now
Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the right set of vehicles to either preserve or grow money can often seem to be a ...
Roivant Sciences Ltd. (NASDAQ:ROIV) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Roivant First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
